Información del artículo
Sesión extraordinaria de la revista ENDOCRINOLOGÍA Y NUTRICIÓN, celebrada en la Acadèmia de Ciències Mèdiques de Catalunya i Balears de Barcelona, el 25 de enero del 2001 bajo el patrocinio de la Societat Catalana d'Endocrinologia i Nutrició.
Agradecemos a los Dres. J. Soler Ramón, O. Giménez y M. Pérez de la Ciutat Sanitària i Universitària de Bellvitge de Barcelona la cesión del caso clinicopatológico.
Palabras clave:
Hirsutismo
Hiperandrogenismo Amenorrea
Adenoma suprarrenal
El Texto completo está disponible en PDF
Bibliografía
[1.]
L. Ibanez, N. Potau, M. Zampolli, N. Prat, R. Virdis, E Vicens Calvet, et al.
Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism.
J Clin Endocrinol Metab, 81 (1996), pp. 1237-1243
[2.]
W. Waggoner, L.R. Boots, R. Azziz.
Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
Gynecol Endocrinol, 13 (1999), pp. 394-400
[3.]
J.L. Gabrilove, A.T. Seman, R. Sabet, H.A. Mitty, G.L. Nicolis.
Virilizing adrenal adenoma with studies on the steroid content of the adrenal venous effluent and a review of the literature.
Endocr Rev, 2 (1981), pp. 462-470
[4.]
D. Soranno, V. Prasad, R. David, S. Oberfield, A. Greco, N. Sivaraman, et al.
Hypertension and virilization caused by a unique desoxycorticosterone-and androgen-secreting adrenal adenoma.
J Pediatr Endocrinol Metab, 12 (1999), pp. 215-220
[5.]
E. Delgrange, P. Goethals, A. Laka, D. Maiter, M. Lambert.
An unusual case of bilateral virilizing adrenal adenoma co-secreting androgens and cortisol.
J Endocrinol Invest, 19 (1996), pp. 377-381
[6.]
D.N. Orth.
Establishing the diagnosis of Cushing's syndrome.
Up To Date in Endocrinology and Metabolism, pp. 8-13
[7.]
D.C. Aron, H. Raff, J.W. Finding.
Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
J Clin Endocrinol Metab, 82 (1997), pp. 1780-1785
[8.]
J. Derksen, S.K. Nagesser, A.E. Meinders, H.R. Haak, C.J. Van de Velde.
Identification of virilizing adrenal tumors in hirsute women.
N Engl J Med, 331 (1994), pp. 968-973
[9.]
H. Escobar-Morreale, F. Pazos, N. Potau, R. Garcia-Robles, J.M. Sancho, C. Varela.
Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha.
Fertil Steril, 62 (1994), pp. 521-530
[10.]
M.D. Gross, B. Shapiro, J.A. Bouffard, G.M. Glazer, I.R. Francis, G.P. Wilton, et al.
Distinguishing benign from malignant euadrenal masses.
Ann Intern Med, 109 (1988), pp. 613-618
[11.]
F. Beuschlein, E. Schulze, P. Mora, H. Gensheimer, C. Maser-Gluth, B. Allolio, et al.
Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors.
J Clin Endocrinol Metab, 83 (1998), pp. 2585-2588
[12.]
R. Ravichandran, F. Lafferty, M. McGinniss, H.C. Taylor.
Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency.
J Clin Endocrinol Metab,, 81 (1996), pp. 1776-1779
[13.]
S. Jaresch, E. Kornely, H. Kley.
Schlaghecke. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.
J Clin Endocrinol Metab,, 74 (1992), pp. 685-689
[14.]
M. Kjellman, M. Holst, Backdahl, C. Larsson, L.O. Farnebo, A. Weddel.
No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours.
Clin Endocrinol (Oxf),, 50 (1999), pp. 343-346
[15.]
M. Shimshi, F. Ross, A. Goodman, L. Gabrilove.
Virilizing adrenocortical tumor superimposed on congenital adrenocortical hyperplasia.
Am J Med, 93 (1992), pp. 338-342
[16.]
V. Bhatia, R. Shukla, S. Mishra, R. Gupta.
Adrenal tumor complicating untreated 21-hydroxylase deficiency in a 5 1/2-year-old boy.
Am J Dis Child, 147 (1993), pp. 1321-1323
[17.]
G. Hamwi, R. Serbin, F. Kruger.
Does adrenocortical hyperplasia result in adrenocortical carcinoma?.
N Engl J Med, 257 (1957), pp. 1153-1157
[18.]
A. Bauman, G. Bauman.
Virilizing adrenocortical carcinoma.
JAMA, 248 (1982), pp. 3140-3141
[19.]
S. Nagasaka, K. Kubota, T. Motegi, E. Hayashi, M. Onta, K. Takahashi, et al.
A case of silent 21-hydroxylase deficiency with persistent adrenal insufficiency after removal of an adrenal incidentaloma.
Clin Endocrinol (Oxf), 44 (1996), pp. 111-116
[20.]
M. Terzolo, G. Osella, A. Ali, G. Borretta, G.P. Magro, A. Termine, et al.
Different patterns of steroid secretion in patients with adrenal incidentaloma.
J Clin Endocrinol Metab, 81 (1996), pp. 740-744
[21.]
H. Sasano, T. Suzuki, H. Nagura, T. Nishikawa.
Steroidogenesis in human adrenocortical carcinoma.
Hum Pathol, 24 (1993), pp. 397-404
[22.]
M. Bondanelli, M. Campo, G. Trasforini, M.R. Ambrosio, M.C. Zatelli, P. Franceschetti, et al.
Evaluation of hormonal function in a series of Incidentally discovered adrenal masses.
Metabolism, 46 (1997), pp. 107-113
[23.]
M. Toth, K. Raez, E. Glaz.
Increased plasma 17-hydroxyprogesterone response to ACTH in patients with nonhyperfunctioning adrenal adenomas is not due to a deficiency in 21-hydroxylase activity (carta).
J Clin Endocrinol Metab, 83 (1998), pp. 3756
[24.]
M. Reincke, J. Nieke, G. Krestin, W. Saeger, B. Allolio, W. Winkelnan.
Preclinical Cushing's syndrome in adrenal “gincidentalomas”: comparison with adrenal Cushing's syndrome.
J Clin Endocrinol Metab, 75 (1992), pp. 826-832
[25.]
T. Seppel, R. Schalaghcke.
Augmented 17α-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours (“gincidentalomas”).
Clin Endocrinol (Oxf), 41 (1994), pp. 445-451
[26.]
M. New.
Diagnosis and management of congenital adrenal hyperplasia.
Ann Rev Med, 49 (1998), pp. 311-328
[27.]
R.A. Lobo, E. Carmina.
The importance of diagnosing the polycystic ovary syndrome.
Ann Intern Med, 132 (2000), pp. 989-993
Copyright © 2001. Sociedad Española de Endocrinología y Nutrición